Article
[Efficacy and safety of pegylated interferon α-2b injection (Y shape, 40 kD) in treatment of patients with genotype 1/6 chronic hepatitis C].
Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology - 20 Mar 2017
Feng B, Shang J, Wu S H, Chen H, Han Y, Li Y Q, Zhang D Z, Zhao L F, Wei S F, Mao Q, Yin C B, Han T, Wang M R, Chen S J, Li J, Xie Q, Zhen Z, Gao Z L, Zhang Y X, Gong G Z, Yang D L, Pan C, Sheng J F, Tang H, Ning Q, Shi G F, Niu J Q, Luo G H, Sun Y T, You H, Wang G Q, Zhang L L, Peng J, Zhang Q, Liu J J, Chen C W, Chen X Y, Zhao W, Wang R H, Sun L, Wei L
Abstract excerpt
Objective: To investigate the efficacy and safety of the new investigational drug pegylated interferon α-2b (Peg-IFN-α-2b) (Y shape, 40 kD) injection (180 µg/week) combined with ribavirin in the treatment of patients with genotype 1/6 chronic hepatitis C (CHC), with standard-dose Peg-IFN-α-2a combined with ribavirin as a positive control. Methods: A multicenter, randomized, open-label, and positive-controlled...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
